Big Move For Polaryx Therapeutics Inc.

Tue, Mar 10, 2026 at 07:25 PM

Polaryx Therapeutics Inc. (PLYX:NASDAQ) rocketted at $5.97, a gain of 69.6%. On Tue, Mar 10, 2026, PLYX:NASDAQ touched a New 2-Week High of $5.97. The stock got featured on our News Catalysts scanner on Tue, Feb 17, 2026 at 11:45 AM in the 'BIOTECH' category. From Tue, Feb 24, 2026, the stock recorded 40.00% Up Days and 63.64% Green Days

About Polaryx Therapeutics Inc. (PLYX:NASDAQ)

Polaryx Therapeutics is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal...

Top 10 Gainers:

Agape ATP Corporation (ATPC:NASDAQ), 87.13%
Polaryx Therapeutics Inc. (PLYX:NASDAQ), 69.6%
Longeveron Inc. (LGVN:NASDAQ), 68.27%
Decent Holding Inc. (DXST:NASDAQ), 50.42%
Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 48.34%
MacroGenics, Inc. (MGNX:NASDAQ), 45.34%
Nauticus Robotics, Inc. (KITT:NASDAQ), 42.46%
Zenvia Inc. (ZENV:NASDAQ), 41.33%
N2OFF, Inc. (NITO:NASDAQ), 38.64%
Murano Global Investments Plc (MRNO:NASDAQ), 38.08%